Keranetics: Winston-Salem biotech raises $2.1M for wound healing tech after merger
Recently merged Keranetics, now Keratin Biosciences, has raised the bulk of an equity-debt round aimed at $2.4 million.
Read full article »
Kinetics is a biomaterials firm focused on creating keratin-based products for trauma care.
Read more